• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Sep 1;28(10).
doi: 10.3201/eid2810.220321. Online ahead of print.
Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland

Aline Wolfensberger, Verena Kufner, Maryam Zaheri, Marius Zeeb, Isabelle Nortes, Peter W Schreiber, Miriam Vazquez, Verena Schärer, Thomas Scheier, Stefan Schmutz, Elisabeth Probst, Dirk Saleschus, Michael Huber, Silvana K Rampini, Walter Zingg

Abstract

Of 1,118 patients with COVID-19 at a university hospital in Switzerland during October 2020-June 2021, we found 83 (7.4%) had probable or definite healthcare-associated COVID-19. After in-hospital exposure, we estimated secondary attack rate at 23.3%. Transmission was associated with longer contact times and with lower cycle threshold values among index patients.

Keywords: COVID-19; SARS-COV-2; Switzerland; coronavirus disease; cross-infection; infection control; infectious disease transmission; nosocomial infections; risk factors; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom